Cited by 599Cystic Fibrosis Research AdvancesBacterial biofilms and quorum sensingMicrobial Community Ecology and Physiology

The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.

Decade-long bacterial community dynamics in cystic fibrosis airways

Open access

Zhao, Jiangchao, Schloss, Patrick D., Kalikin, Linda M., Carmody, Lisa A., Foster, Bridget K., Petrosino, Joseph F., Cavalcoli, James D., VanDevanter, Donald R., Murray, Susan, Li, Jun Z., Young, Vincent B., LiPuma, John J.·2012·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1120577109PMC PMC3326496

Open this paper in CoChat — free account

Abstract

The structure and dynamics of bacterial communities in the airways of persons with cystic fibrosis (CF) remain largely unknown. We characterized the bacterial communities in 126 sputum samples representing serial collections spanning 8-9 y from six age-matched male CF patients. Sputum DNA was analyzed by bar-coded pyrosequencing of the V3-V5 hypervariable region of the 16S rRNA gene, defining 662 operational taxonomic units (OTUs) from >633,000 sequences. Bacterial community diversity decreased significantly over time in patients with typically progressive lung disease but remained relatively stable in patients with a mild lung disease phenotype. Antibiotic use, rather than patient age or lung function, was the primary driver of decreasing diversity. Interpatient variability in community structure exceeded intrapatient variability in serial samples. Antibiotic treatment was associated with pronounced shifts in community structure, but communities showed both short- and long-term resilience after antibiotic perturbation. There was a positive correlation between OTU occurrence and relative abundance, with a small number of persistent OTUs accounting for the greatest abundance. Significant changes in community structure, diversity, or total bacterial density at the time of pulmonary exacerbation were not observed. Despite decreasing community diversity in patients with progressive disease, total bacterial density remained relatively stable over time. These findings show the critical relationship between airway bacterial community structure, disease stage, and clinical state at the time of sample collection. These features are the key parameters with which to assess the complex ecology of the CF airway.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.1120577109

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Self-citation
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set
Nadkarni, M. A., Martin, F. E., Jacques, N. A., & Hunter, N. (2002) · Microbiology · doi:10.1099/00221287-148-1-257 · Cited by 1,931
Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis
Tunney, M. M., Field, T. R., Moriarty, T. F., Patrick, S., Doering, G., Muhlebach, M. S., Wolfgang, M. C., Boucher, R. C., Gilpin, D. F., McDowell, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1151oc · Cited by 466
Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
Cox, M. J., Allgaier, M., Taylor, B., Baek, M. S., Huang, Y. J., Daly, R. A., Karaöz, U., Andersen, G. L., Brown, R., Fujimura, K. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011044 · Cited by 458
Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis
Harris, J. K., Groote, M. A. D., Sagel, S. D., Zemanick, E. T., Kapsner, R. K., Penvari, C., Kaess, H., Deterding, R. R., Accurso, F. J., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709804104 · Cited by 373
Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P., Jones, G., & Bruce, K. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5176-5183.2004 · Cited by 316
A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients
Sibley, C. D., Parkins, M. D., Rabin, H. R., Duan, K., Nørgaard, J. C., & Surette, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804326105 · Cited by 311
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities
Gast, C., Walker, A. W., Stressmann, F. A., Rogers, G. B., Scott, P., Daniels, T. W. V., Carroll, M. P., Parkhill, J., & Bruce, K. D. (2010) · The ISME Journal · doi:10.1038/ismej.2010.175 · Cited by 265
Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa
Klepac‐Ceraj, V., Lemon, K. P., Martin, T. R., Allgaier, M., Kembel, S. W., Knapp, A. A., Lory, S., Brodie, E., Lynch, S. V., Bohannan, B. J. M., et al. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02173.x · Cited by 219

Show all 18 references

Sorted by citations

Items 401–500 of 594

An oral commensal attenuates Pseudomonas aeruginosa -induced airway inflammation and modulates nitrite flux in respiratory epithelium
Baty, J. J., Stoner, S. N., McDaniel, M. S., Huffines, J. T., Edmonds, S. E., Evans, N. J., Novak, L., & Scoffield, J. A. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02198-23 · Cited by 10
Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations
Houston, C. J., Alkhatib, A., Einarsson, G. G., Tunney, M. M., Taggart, C. C., & Downey, D. G. (2023) · European Respiratory Journal · doi:10.1183/13993003.01228-2023 · Cited by 10
Episodic oral antibiotic use in CF: Discordance between the electronic medical record and self-report
Caverly, L. J., Caverly, T. J., Kalikin, L. M., Foster, B. K., Simon, R. H., & LiPuma, J. J. (2016) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2016.04.009 · Cited by 10
Self-citation
Diagnostic Value of Exhaled Carbon Monoxide as an Early Marker of Exacerbation in Children with Chronic Lung Diseases
Khalek, K. A. A. E., Elseify, M. Y., Youssef, O. I., & Badr, M. M. (2012) · ISRN Pediatrics · doi:10.5402/2012/859873 · Cited by 10
Successful treatment of a unique chronic multi-bacterial scalp infection with N-chlorotaurine, N-bromotaurine and bromamine T
Kyriakopoulos, A. M., Nagl, M., Orth‐Höller, D., Marcinkiewicz, J., Baliou, S., & Zoumbourlis, V. (2020) · Access Microbiology · doi:10.1099/acmi.0.000126 · Cited by 10
Aerially transmitted human fungal pathogens: What can we learn from metagenomics and comparative genomics?
Aliouat‐Denis, C., Chabé, M., Delhaès, L., & Dei‐Cas, E. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.10.006 · Cited by 10
Genome-scale model of Rothia mucilaginosa predicts gene essentialities and reveals metabolic capabilities
Leonidou, N., Ostyn, L., Coenye, T., Crabbé, A., & Dräger, A. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04006-23 · Cited by 9
New Insights in Microbial Species Predicting Lung Function Decline in CF: Lessons from the MucoFong Project
Francis-Oliviero, F., Enaud, R., Soret, P., Lussac‐Sorton, F., Avalos, M., MucoFong Investigation Group, Bui, S., Fayon, M. J., Thiébaut, R., & Delhaès, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163725 · Cited by 9
Unexpected associations between respiratory viruses and bacteria with Pulmonary Function Testing in children suffering from Cystic Fibrosis (MUCOVIB study)
Scherz, V., Caruana, G., Taffé, P., Brouillet, R., Bertelli, C., Jaton, K., Fougère, Y., Posfay-Barbe, K. M., Mornand, A., Rochat, I., et al. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.10.001 · Cited by 9
Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes
Thornton, C. S., Magaret, A., Carmody, L. A., Kalikin, L. M., Simon, R. H., LiPuma, J. J., & Caverly, L. J. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.05.011 · Cited by 10
Self-citation
Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa
Pagès-Monteiro, L., Marti, R., Commun, C., Alliot, N., Bardel, C., Meugnier, H., de Montclos, M. P., Reix, P., Durieu, I., Durupt, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173022 · Cited by 12
Characterization of the Microbiome and Host’s Metabolites of the Lower Respiratory Tract During Acute Community-Acquired Pneumonia Identifies Potential Novel Markers
Xiao, Q., Tan, S., Liu, C., Liu, B., Li, Y., Guo, Y., Hu, P., Su, Z., Chen, S., Lei, W., et al. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s394779 · Cited by 9
Comparative analysis of microbiome between accurately identified 16S rDNA and quantified bacteria in simulated samples
Wang, H., Du, P., Li, J., Zhang, Y., Zhang, W., Han, N., Woo, P. C. Y., & Chen, C. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.060616-0 · Cited by 9
Self-citation
“Pathogen Eradication” and “Emerging Pathogens”: Difficult Definitions in Cystic Fibrosis
Gilligan, P. H., Downey, D. G., Elborn, J. S., Flume, P. A., Funk, S., Gilpin, D. F., Kidd, T. J., McCaughan, J., Millar, B. C., Murphy, P. G., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00193-18 · Cited by 9
Lower airway microbiota for ‘biomarker’ measurements of cystic fibrosis disease progression?
Sherrard, L. J., & Bell, S. C. (2018) · Thorax · doi:10.1136/thoraxjnl-2018-212165 · Cited by 9
Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis
Vieira, J., Jesudasen, S. J., Bringhurst, L., Sui, H., McIver, L. J., Whiteson, K., Hanselmann, K. W., O’Toole, G. A., Richards, C. J., Sicilian, L., et al. (2022) · mSystems · doi:10.1128/msystems.00364-22 · Cited by 10
Analysis of airway microbiota in adults from a Brazilian cystic fibrosis center
Leite, C. C. F., de Freitas, F. A. D., Firmida, M. D. C., Leão, R. S., Albano, R. M., & Marques, E. A. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00381-3 · Cited by 8
Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders
Scialò, F., Vitale, M., D’Agnano, V., Mariniello, D. F., Perrotta, F., Castaldo, A., Campbell, S. F. M., Pastore, L., Cazzola, M., & Bianco, A. (2023) · Lung · doi:10.1007/s00408-023-00645-3 · Cited by 8
Respiratory infection rates differ between geographically distant paediatric cystic fibrosis cohorts
Ramsey, K. A., Hart, E. J., Turkovic, L., Padros-Goossens, M., Stick, S. M., & Ranganathan, S. (2016) · ERJ Open Research · doi:10.1183/23120541.00014-2016 · Cited by 8
Activity of pulmonary vancomycin exposures versus planktonic and biofilm isolates of methicillin-resistant Staphylococcus aureus from cystic fibrosis sputum
Britt, N. S., Hazlett, D. S., Horvat, R. T., Liesman, R. M., & Steed, M. E. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105898 · Cited by 8
Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis
Hahn, A., Burrell, A., Chaney, H. R., Sami, I. R., Koumbourlis, A. C., Freishtat, R. J., Zemanick, E. T., Louie, S. G., & Crandall, K. A. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2021-001824 · Cited by 8
The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia
Law, J. P., Wood, A. J., & Friman, V. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01842-22 · Cited by 8
Longitudinal analysis of sinus microbiota post endoscopic surgery in patients with cystic fibrosis and chronic rhinosinusitis: a pilot study
Mackenzie, B. W., Dassi, C., Vivekanandan, A., Zoing, M., Douglas, R. G., & Biswas, K. (2021) · Respiratory Research · doi:10.1186/s12931-021-01697-w · Cited by 8
Current Approaches to the Management of Infection in Cystic Fibrosis
Elborn, J. S. (2013) · Current Pediatrics Reports · doi:10.1007/s40124-013-0024-6 · Cited by 7
A population-level strain genotyping method to study pathogen strain dynamics in human infections
Morgan, S. J., Durfey, S. L., Ravishankar, S., Jorth, P. A., Ni, W., Skerrett, D. T., Aitken, M. L., McKone, E. F., Salipante, S. J., Radey, M. C., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.152472 · Cited by 7
Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation
Inam, Z. S., Felton, E., Burrell, A., Chaney, H. R., Sami, I. R., Koumbourlis, A. C., Freishtat, R. J., Zemanick, E. T., Crandall, K. A., & Hahn, A. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac466 · Cited by 7
Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment
Einarsson, G. G., Sherrard, L. J., Hatch, J., Zorn, B., Johnston, E., McGettigan, C., O’Neill, K., Gilpin, D. F., Downey, D. G., Murray, M., et al. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.11.010 · Cited by 7
Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics
McDermott, G., Walsh, A. M., Crispie, F., Frost, S., Greally, P., Cotter, P. D., O’Sullivan, Ó., & Renwick, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073893 · Cited by 7
An integrated metaproteomics workflow for studying host-microbe dynamics in bronchoalveolar lavage samples applied to cystic fibrosis disease
Kruk, M., Mehta, S., Murray, K. J., Higgins, L., Do, K., Johnson, J. E., Wagner, R., Wendt, C. H., O’Connor, J. B., Harris, J. K., et al. (2024) · mSystems · doi:10.1128/msystems.00929-23 · Cited by 7
The effect of levofloxacin on the lung microbiota of laboratory rats
Finn, S. M. B., Scheuermann, U., Holzknecht, Z. E., Gao, Q., Ibrahim, M. M., Parker, W., Granek, J. A., Lin, S. S., McKenney, E. A., & Barbas, A. S. (2019) · Experimental Lung Research · doi:10.1080/01902148.2019.1639225 · Cited by 8
Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs
Einarsson, G. G., Vanaudenaerde, B. M., Spence, C. D., Lee, A. J., Boon, M., Verleden, G. M., Elborn, J. S., Dupont, L., Raemdonck, D. E. V., Gilpin, D. F., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.764585 · Cited by 7
Airway bacterial community composition in persons with advanced cystic fibrosis lung disease
Thornton, C. S., Carmody, L. A., Kalikin, L. M., Opron, K., Caverly, L. J., & LiPuma, J. J. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.01.001 · Cited by 7
Self-citation
Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screen
Harris, J. K., Wagner, B. D., Robertson, C. E., Stevens, M. J., Lingard, C., Borowitz, D., Leung, D. H., Heltshe, S. L., Ramsey, B. W., & Zemanick, E. T. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.04.017 · Cited by 7
Exploring the Parallel Development of Microbial Systems in Neonates with Cystic Fibrosis
Rogers, G. B., & Bruce, K. D. (2012) · mBio · doi:10.1128/mbio.00408-12 · Cited by 7
Draft Genome Sequences of Seven Pseudomonas fluorescens Subclade III Strains Isolated from Cystic Fibrosis Patients
Scales, B. S., Erb‐Downward, J. R., Huffnagle, I. M., LiPuma, J. J., & Huffnagle, G. B. (2015) · Genome Announcements · doi:10.1128/genomea.01285-14 · Cited by 7
Self-citation
Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity
Hahn, A., Bendall, M. L., Gibson, K. M., Chaney, H. R., Sami, I. R., Pérez, G. F., Koumbourlis, A. C., McCaffrey, T. A., Freishtat, R. J., & Crandall, K. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01069 · Cited by 7
The Versatile Type VI Secretion System
Alteri, C. J., & Mobley, H. L. T. (2016) · ASM Press eBooks · doi:10.1128/9781555819286.ch12 · Cited by 7
Airway Microbiome in Children with Cystic Fibrosis: A Review of Microbial Shifts and Therapeutic Impacts
Buruiană, G., Sima, C. M., Anton-Păduraru, D.-T., Bădescu, A. C., Luncă, C., Duhaniuc, A., & Dorneanu, O. (2025) · Medicina · doi:10.3390/medicina61091605 · Cited by 6
The Microbiome and Pulmonary Immune Function
Baker, J. M., & Dickson, R. P. (2024) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2024.10.006 · Cited by 6
Microbiology of the Cystic Fibrosis Airway
McDermott, G., Reece, E., & Renwick, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.90263-2 · Cited by 6
Regional differences in infection and structural lung disease in infants and young children with cystic fibrosis
Carzino, R., Frayman, K. B., King, L., Vidmar, S., & Ranganathan, S. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.10.018 · Cited by 6
Standards in Biologic Lesions: Cutaneous Thermal Injury and Inhalation Injury Working Group 2018 Meeting Proceedings
Moffatt, L. T., Madrzykowski, D. M., Gibson, A. L. F., Powell, H. M., Cancio, L. C., Wade, C. E., Choudhry, M. A., Kovacs, E. J., Finnerty, C. C., Majetschak, M., et al. (2020) · Journal of Burn Care & Research · doi:10.1093/jbcr/irz207 · Cited by 6
Le résistome pulmonaire
Brégeon, F., & Rolain, J. (2015) · médecine/sciences · doi:10.1051/medsci/20153111003 · Cited by 6
Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis
Kramná, L., Dřevı́nek, P., Lin, J., Kulich, M., & Cinek, O. (2017) · Folia Microbiologica · doi:10.1007/s12223-017-0562-3 · Cited by 6
Meta-Analysis Reveals Potential Influence of Oxidative Stress on the Airway Microbiomes of Cystic Fibrosis Patients
Shi, X., Gao, Z., Lin, Q., Zhao, L., Ma, Q., Kang, Y., & Yu, J. M. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.03.009 · Cited by 6
Comparison of the airway microbiota in children with chronic suppurative lung disease
Ahmed, B., Cox, M. J., Cuthbertson, L., James, P. L., Gardner, L., Cookson, W., Davies, J. C., Moffatt, M. F., & Bush, A. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-001106 · Cited by 6
Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function
Bozzella, M. J., Chaney, H. R., Sami, I. R., Koumbourlis, A. C., Bost, J. E., Zemanick, E. T., Freishtat, R. J., Crandall, K. A., & Hahn, A. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003211 · Cited by 6
Impact at school age of early chronic methicillin‐sensitive Staphylococcus aureus infection in children with cystic fibrosis
Galodé, F., Dournes, G., Chateil, J., Fayon, M. J., Collet, C., & Bui, S. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24906 · Cited by 6
Beyond the organ: lung microbiome shapes transplant indications and outcomes
Ponholzer, F., Bogensperger, C., Krendl, F. J., Krapf, C., Dumfarth, J., Schneeberger, S., & Augustin, F. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae338 · Cited by 5
Lower airway microbiota and decreasing lung function in young Brazilian cystic fibrosis patients with pulmonary Staphylococcus and Pseudomonas infection
Kussek, P. C., Mesa, D., Vasconcelos, T. M., Rodrigues, L. S., Krul, D., Ibañez, H. C., Faoro, H., Palmeiro, J. K., & Dalla-Costa, L. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273453 · Cited by 5
A Polyclonal Antibody against a Burkholderia cenocepacia OmpA-like Protein Strongly Impairs Pseudomonas aeruginosa and B. multivorans Virulence
Seixas, A. M. M., Gomes, S. C., Silva, C., Moreira, L. M., Leitão, J. H., & Sousa, S. A. (2024) · Vaccines · doi:10.3390/vaccines12020207 · Cited by 5
Contribution of the infection ecosystem and biogeography to antibiotic failure in vivo
Nazeer, R. R., Askenasy, I., Swain, J. E. V., & Welch, M. (2024) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00063-2 · Cited by 5
Diagnosis and insight into the unique lung microbiota of pediatric pulmonary tuberculosis patients by bronchoalveolar lavage using metagenomic next-generation sequencing
Zhou, H., Pei, Y., Xie, Q., Nie, W., Liu, X., Xia, H., & Jiang, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1492881 · Cited by 5
Cystic fibrosis in the era of genomic medicine
Milla, C. E. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328360dbf5 · Cited by 5
Gram-negative bacteria act as a reservoir for aminoglycoside antibiotics that interact with host factors to enhance bacterial killing in a mouse model of pneumonia
Wijers, C. D. M., Pham, L., Douglass, M. V., Skaar, E. P., Palmer, L. D., & Noto, M. J. (2022) · FEMS Microbes · doi:10.1093/femsmc/xtac016 · Cited by 5
Single nucleotide variants in Pseudomonas aeruginosa populations from sputum correlate with baseline lung function and predict disease progression in individuals with cystic fibrosis
Saber, M. M., Donner, J., Levade, I., Acosta, N., Parkins, M. D., Boyle, B., Lévesque, R. C., Nguyen, D. M., & Shapiro, B. J. (2023) · Microbial Genomics · doi:10.1099/mgen.0.000981 · Cited by 5
98 The cystic fibrosis lower airways microbial metagenome
Losada, P. M., Chouvarine, P., Dorda, M., Hedtfeld, S., Mielke, S., Schulz, A., Wiehlmann, L., & Tümmler, B. (2016) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(16)30337-x · Cited by 5
Phenotypes That Matter: Pseudomonas aeruginosa and Progression of Cystic Fibrosis Lung Disease
Sanders, D. B. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1145ed · Cited by 5
Microbiome data enhances predictive models of lung function in people with cystic fibrosisPreprint
Zhao, C. Y., Hao, Y., Wang, Y., Varga, J. J., Stecenko, A. A., Goldberg, J. B., & Brown, S. P. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/656066 · Cited by 5
Species turnover within cystic fibrosis lung microbiota is indicative of acute pulmonary exacerbation onset
Cuthbertson, L., Hatfield, L. R., Gavillet, H., Hardman, M., Marsh, R., Rivett, D. W., & Gast, C. (2025) · Microbiome · doi:10.1186/s40168-025-02143-5 · Cited by 4
Microbiota, Mucus, and Modulators: Cystic Fibrosis Infection Pathogenesis in the Cystic Fibrosis Transmembrane Conductance Regulator Modulator Era
Thornton, C. S., Bouzek, D. C., & Caverly, L. J. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf626 · Cited by 4
RNA-seq reproducibility of Pseudomonas aeruginosa in laboratory models of cystic fibrosis
Duncan, R. P., Lewin, G. R., Cornforth, D. M., Diggle, F. L., Kapur, A., Moustafa, D. A., Hilliam, Y., Bomberger, J. M., Whiteley, M., & Goldberg, J. B. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01513-24 · Cited by 4
Next generation microbiology and cystic fibrosis diagnostics
Moser, C. E., Thomsen, T. R., & Høiby, N. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000516 · Cited by 4
Microbiome in Cystic Fibrosis
Caverly, L. J., Hoffman, L. R., & Zemanick, E. T. (2022) · Respiratory medicine · doi:10.1007/978-3-030-87104-8_6 · Cited by 4
Probiotic Formulation Development and Local Application with Focus on Local Buccal, Nasal and Pulmonary Application
Lima-Engelmann, K., & Schneider, M. (2022) · Current Nutraceuticals · doi:10.2174/2665978604666221122112434 · Cited by 4
Polymicrobial Biofilms in Cystic Fibrosis Lung Infections: Effects on Antimicrobial Susceptibility
Galdino, A. C. M., Vaillancourt, M., Celedonio, D., & Jorth, P. A. (2022) · Springer series on biofilms · doi:10.1007/978-3-031-15349-5_7 · Cited by 5
Universal soldier: Pseudomonas aeruginosa — an opportunistic generalist
Gross, J., Passmore, I. J., Chung, J. C. S., Rzhepishevska, O. I., Ramstedt, M., & Welch, M. (2013) · Frontiers in Biology · doi:10.1007/s11515-013-1267-x · Cited by 4
The Emergence of Streptococcus anginosus Group as a Cystic Fibrosis Pathogen
Hill, E. M. (2017) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2017.09.002 · Cited by 4
Fungal Infections and ABPA
Aogáin, M. M., Vidaillac, C., & Chotirmall, S. H. (2020) · Respiratory medicine · doi:10.1007/978-3-030-42382-7_6 · Cited by 4
Metabolism and Pathogenicity ofPseudomonas aeruginosaInfections in the Lungs of Individuals with Cystic Fibrosis
Palmer, G. C., & Whiteley, M. (2015) · ASM Press eBooks · doi:10.1128/9781555818883.ch9 · Cited by 5
Le microbiote pulmonaire
Ploton, M., Abakka, S., Amouyal, E., Besnard, C., Dufour, L., Harrif, S. E., Kipnis, C., Prim, B., Vignot, J. L., & Houdouin, V. (2017) · Archives de Pédiatrie · doi:10.1016/j.arcped.2017.04.007 · Cited by 6
Cystic fibrosis airway epithelial cells have an exaggerated response to hypoxia that is partially reversible through transmembrane receptor modulation
Brunet‐Ratnasingham, E., Tsao, T., Mohanty, R. P., Arias-Soto, O., Kapse, B., Greenland, J. R., & Calabrese, D. R. (2025) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2025.08.002 · Cited by 3
A metagenomic next-generation sequencing (mNGS)-based analysis of bronchoalveolar lavage samples in patients with an acute exacerbation of chronic obstructive pulmonary disease
Wu, J., Zhang, Y., Duan, J., Wei, Y., & Miao, Y. (2024) · Journal of Molecular Histology · doi:10.1007/s10735-024-10225-1 · Cited by 3
An effective response to respiratory inhibition by a Pseudomonas aeruginosa excreted quinoline promotes Staphylococcus aureus fitness and survival in co-culture
Román‐Rodríguez, F., Tyagi, N., Kim, J., Parker, D., & Boyd, J. M. (2025) · Journal of Bacteriology · doi:10.1128/jb.00101-25 · Cited by 3
Utilization and control of ecological interactions in polymicrobial infections and community-based microbial cell factories
Wigneswaran, V., Amador, C. I., Jelsbak, L., Sternberg, C., & Jelsbak, L. (2016) · F1000Research · doi:10.12688/f1000research.7876.1 · Cited by 3
Gram negative infections in cystic fibrosis: a review of preventative and treatment options
Addy, C., Caskey, S., & Downey, D. G. (2020) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2020.1713748 · Cited by 3
Co-occurring microflora and mucin drive Pseudomonas aeruginosa diversification and pathoadaptation
Bottery, M. J., Johansen, H. K., Pitchford, J. W., & Friman, V. (2024) · ISME Communications · doi:10.1093/ismeco/ycae043 · Cited by 3
Clinical epidemiology and impact of Haemophilus influenzae airway infections in adults with cystic fibrosis
Weyant, R. B., Waddell, B. J. M., Acosta, N., Izydorczyk, C., Conly, J. M., Church, D. L., Surette, M. G., Rabin, H. R., Thornton, C. S., & Parkins, M. D. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10050-7 · Cited by 3
Modeling association in microbial communities with clique loglinear models
Dobra, A., Valdes, C., Ajdić, D., Clarke, B. S., & Clarke, J. (2019) · The Annals of Applied Statistics · doi:10.1214/18-aoas1229 · Cited by 3
Antigen-Presenting Cells in the Airways: Moderating Asymptomatic Bacterial Carriage
Slimmen, L. J. M., Janssens, H. M., van Rossum, A. M. C., & Unger, W. W. J. (2021) · Pathogens · doi:10.3390/pathogens10080945 · Cited by 3
A pilot study investigating the effects of a manuka honey sinus rinse compared to a standard sinus rinse on sino-nasal outcome test scores in cystic fibrosis patients
Roberts, A. E. L., Xanthe, C., Hopkins, A. L., Bodger, O. G., Lewis, P., Mahenthiralingam, E., Duckers, J. M., & Jenkins, R. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-01175-0 · Cited by 3
Integrating airway microbiome and blood proteomics data to identify multi-omic networks associated with response to pulmonary infection
Graham, B. I. M., Harris, J. K., Zemanick, E. T., & Wagner, B. D. (2023) · The Microbe · doi:10.1016/j.microb.2023.100023 · Cited by 3
Diversité physiopathologique du microbiote respiratoire
Michon, A.-L., & Marchandin, H. (2015) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(15)72820-0 · Cited by 5
The Cystic Fibrosis Airway Microbiome and Pathogens
Janahi, I. A., & Rehman, A. (2017) · InTech eBooks · doi:10.5772/67846 · Cited by 3
Pseudomonas aeruginosa and Bronchiectasis
Soyza, A. D., & Winstanley, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-61452-6_12 · Cited by 3
Bacterial Infections and the Respiratory Microbiome
Waters, V. J., & LiPuma, J. J. (2020) · Respiratory medicine · doi:10.1007/978-3-030-42382-7_5 · Cited by 3
Self-citation
Clinical metagenomics for infection diagnosis
Schlaberg, R., & Filkins, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801496-7.00004-6 · Cited by 3
Lessons from the lower airway microbiome in early CF
Hoppe, J. E., & Zemanick, E. T. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210060 · Cited by 3
Inflammation, age and changing microbiology: the search for causation in the cystic fibrosis airways
Rogers, G. B. (2017) · European Respiratory Journal · doi:10.1183/13993003.01935-2017 · Cited by 3
Taxonomic variability over functional stability in the microbiome of Cystic Fibrosis patients chronically infected by Pseudomonas aeruginosaPreprint
Bacci, G., Taccetti, G., Dolce, D., Armanini, F., Segata, N., Cesare, F. D., Lucidi, V., Fiscarelli, E. V., Morelli, P., Casciaro, R., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/609057 · Cited by 3
Metagenomic analysis after selective culture enrichment of wastewater demonstrates increased burden of antibiotic resistant genes in hospitals relative to the communityPreprint
Acosta, N., 이장우, Bautista, M. A., Bhatnagar, S., Waddell, B. J. M., Au, E., Pradhan, P., Clark, R. G., Meddings, J. B., Ruecker, N. J., et al. (2023) · medRxiv · doi:10.1101/2023.03.07.23286790 · Cited by 3
The effect of Staphylococcus aureus on the persistence of Pseudomonas aeruginosa due to aggregation in cystic fibrosis airway infections
Morris, A. J., Eisha, S., Yau, Y. C. W., DePas, W. H., Fabiano, G., Aberdein, S., Faisal, L., Martin, I., Selvarajah, A., Gaudet, M., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116016 · Cited by 2
Spontaneous lung colonization in the cystic fibrosis rat model is linked to gastrointestinal obstruction
Murphree-Terry, M., Keith, J. D., Oden, A. M., & Birket, S. E. (2025) · mBio · doi:10.1128/mbio.03883-24 · Cited by 2
Exploring the role of microbiome in cystic fibrosis clinical outcomes through a mediation analysis
Koldaş, S. S., Sezerman, O. U., & Timuçin, E. (2025) · mSystems · doi:10.1128/msystems.00196-25 · Cited by 2
Symposium Summaries
(2015) · Pediatric Pulmonology · doi:10.1002/ppul.23296 · Cited by 2
T100: nebulized-concentrated tobramycin formulation for treatment ofPseudomonas aeruginosainfection in cystic fibrosis patients
Ehsan, Z., & Clancy, J. P. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1064308 · Cited by 2
A Whole-Cell-Based High-Throughput Screening Method to Identify Molecules Targeting Pseudomonas aeruginosa Persister Cells
Liebens, V., Defraine, V., & Fauvart, M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2854-5_10 · Cited by 2
Assessing the Airway Microbiota in Cystic Fibrosis
Hoppe, J. E., Harris, J. K., & Zemanick, E. T. (2016) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2016.10.004 · Cited by 2
The first study characterizing the respiratory microbiome in cystic fibrosis patients in Jordan
Alsayed, A. R., Abed, A. I., Zihlif, M. A., Abu‐Samak, M., Almuhur, R. A., & Alkhatib, M. (2023) · Pharmacy Practice · doi:10.18549/pharmpract.2023.3.2832 · Cited by 2
Symposium Session Summaries
(2013) · Pediatric Pulmonology · doi:10.1002/ppul.22896 · Cited by 2

Authors: Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., Young, V. B., & LiPuma, J. J.
Affiliations: University of Michigan (US)
Microbiology and Immunology,
Baylor College of Medicine (US)
Case Western Reserve University (US)
Biostatistics and
Human Genetics, and
ORCID: Zhao, Jiangchao
Schloss, Patrick D.
Carmody, Lisa A.
Petrosino, Joseph F.
VanDevanter, Donald R.
Murray, Susan
Li, Jun Z.
Young, Vincent B.
LiPuma, John J.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2012-03-26
Volume: 109
Issue: 15
Pages: 5809-5814
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1120577109
PMC: PMC3326496
OpenAlex: W2094167812
Cited by: 599
References: 18
Citations by year: 2026: 12 · 2025: 18 · 2024: 32 · 2023: 31 · 2022: 37 · 2021: 41 · 2020: 57 · 2019: 57 · 2018: 40 · 2017: 39 · 2016: 50 · 2015: 61 · 2014: 63 · 2013: 43 · 2012: 18
FWCI: 47.73
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Deep Blue (University of Michigan) (submittedVersion)
Funders: National Institutes of Health (5rc1hl100809-02)
National Heart, Lung, and Blood Institute (U01HL098961, RC1-HL100809, 1RC1HL100809-01)
National Human Genome Research Institute (R01HG005975, R01HG004906)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933, P30DK027651)
National Center for Research Resources (UL1RR024986)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Physical Sciences › Environmental Science › Ecology › Microbial Community Ecology and Physiology
Keywords: cystic fibrosis, sputum microbiome, bacterial diversity, antibiotic therapy, community resilience, pulmonary exacerbations, disease progression, 16S rRNA gene sequencing, interpatient variability
MeSH terms: Adolescent, Adult, Aging, Anti-Bacterial Agents, Bacteria, Cystic Fibrosis, Humans, Lung, Male, Respiratory Function Tests, Sputum, Disease Progression, Principal Component Analysis, Biodiversity, Metagenome, Young Adult, Bacterial Load

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Decade-long bacterial community dynamics in cystic fibrosis airways

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks